A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma
Abstract: Phase 3 studies combining histone deacetylase inhibitors with bortezomib were hampered by gastrointestinal (GI) intolerance, which was not observed when combined with immunomodulatory drugs. This study is a single-center phase 2 study of panobinostat with lenalidomide and dexamethasone (FR...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2017-08-01
|
| Serie: | Blood Advances |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2473952920302962 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|